Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,640 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis and characterization of nanocomposite based polymeric membrane (PES/PVP/GO-TiO2) and performance evaluation for the removal of various antibiotics (amoxicillin, azithromycin & ciprofloxacin) from aqueous solution.
Goyat R, Singh J, Umar A, Saharan Y, Ibrahim AA, Akbar S, Baskoutas S. Goyat R, et al. Among authors: singh j. Chemosphere. 2024 Apr;353:141542. doi: 10.1016/j.chemosphere.2024.141542. Epub 2024 Feb 28. Chemosphere. 2024. PMID: 38428535
Nanomaterials-based biosensor and their applications: A review.
Malik S, Singh J, Goyat R, Saharan Y, Chaudhry V, Umar A, Ibrahim AA, Akbar S, Ameen S, Baskoutas S. Malik S, et al. Among authors: singh j. Heliyon. 2023 Sep 7;9(9):e19929. doi: 10.1016/j.heliyon.2023.e19929. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809900 Free PMC article. Review.
Destabilizing Effect of Organo Ru(II) Salts on the Intermolecular Parallel CGG Repeat DNA Quadruplex Associated with Neurodegenerative/Neuromuscular Diseases.
Sathyaseelan C, Veerapathiran S, Das U, Ravichandran G, Ajjugal Y, Singh J, Rengan AK, Rathinavelan T, Prabusankar G. Sathyaseelan C, et al. Among authors: singh j. ACS Chem Neurosci. 2023 Oct 4;14(19):3646-3654. doi: 10.1021/acschemneuro.3c00285. Epub 2023 Sep 12. ACS Chem Neurosci. 2023. PMID: 37698929
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors.
Anderson AE, Parashar K, Jin K, Clor J, Stagnaro CE, Vani U, Singh J, Chen A, Guan Y, Talukdar P, Sathishkumar P, Juat DJ, Singh H, Kushwaha R, Zhao X, Kaplan A, Seitz L, Walters MJ, Fernandez-Salas E, Walker NPC, Bowman CE. Anderson AE, et al. Among authors: singh j. Mol Cancer Ther. 2024 May 27. doi: 10.1158/1535-7163.MCT-23-0865. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38797955
8,640 results